acarviostatins III03 (Nankai University/Tianjin Zhongxin Pharmaceutical Group)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameacarviostatins III03 (Nankai University/Tianjin Zhongxin Pharmaceutical Group)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMaltase-glucoamylase inhibitors
TargetsMaltase-glucoamylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNankai University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNankai University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A